THERAPEUTIC DRUG MONITORING OF INFLIXIMAB AND ADALIMUMAB FOR DETECTION OF PATIENTS AT RISK OF LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE.

Jaime González-López  1     Manuel Barreiro de Acosta  2     José M Giráldez-Montero  3     Rocio Ferreiro Iglesias     María Jesús Lamas-Díaz     Juan Enrique Dominguez-Munoz    
1 University Hospital of Santiago de Compostela, Pharmacy, Santiago de Compostela, Spain
2 University Hospital of Santiago de Compostela. Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain, Gastroenterology, Santiago de Compostela, Spain
3 University Hospital of Santiago de Compostela, Pharmacy, Santiag

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing